Answer
The safety and efficacy of Waylivra (volanesorsen sodium) in children and adolescents below 18 years have not yet been established, and no data are available.
Sources for this answer
- Waylivra (volanesorsen)Akcea Therapeutics UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 7Document updated
Sources checked